TWO · Healthcare

NeoCore Technology Co., Ltd. (4131)

Biotechnology

NeoCore Technology Co., Ltd. (4131) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 4131

P/E ratio

18.00

NeoCore Technology Co., Ltd. (4131) — FAQ

What is 4131's P/E ratio?

The price-to-earnings (P/E) ratio for NeoCore Technology Co., Ltd. (4131) is 18.00 (data as of 2026-03-23).

Does NeoCore Technology Co., Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for NeoCore Technology Co., Ltd. (4131). Check the MyAverix Finance app for the latest dividend data.

What sector is NeoCore Technology Co., Ltd. in?

NeoCore Technology Co., Ltd. (4131) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 4131 listed on?

4131 is listed on TWO.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)